FDA — authorised 12 November 1973
- Application: ANDA083130
- Marketing authorisation holder: ABBOTT
- Local brand name: AMMONIUM CHLORIDE
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 AMMONIUM CHLORIDE in United States
FDA authorised AMMONIUM CHLORIDE on 12 November 1973
Marketing authorisations
FDA — authorised 13 October 1978
- Application: ANDA085734
- Marketing authorisation holder: B BRAUN
- Local brand name: AMMONIUM CHLORIDE 2.14%
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 13 June 1984
- Application: ANDA088366
- Marketing authorisation holder: HOSPIRA
- Local brand name: AMMONIUM CHLORIDE IN PLASTIC CONTAINER
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Status: approved
FDA
- Application: ANDA086205
- Marketing authorisation holder: GD SEARLE LLC
- Local brand name: AMMONIUM CHLORIDE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Application: NDA006580
- Marketing authorisation holder: MCGAW
- Local brand name: AMMONIUM CHLORIDE 0.9% IN NORMAL SALINE
- Indication: INJECTABLE — INJECTION
- Status: approved
AMMONIUM CHLORIDE in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is AMMONIUM CHLORIDE approved in United States?
Yes. FDA authorised it on 12 November 1973; FDA authorised it on 13 October 1978; FDA authorised it on 13 June 1984.
Who is the marketing authorisation holder for AMMONIUM CHLORIDE in United States?
ABBOTT holds the US marketing authorisation.